Function of atypical mammalian oocyte/zygote nucleoli and its implications for reproductive biology and medicine
Language English Country Spain Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
31058290
DOI
10.1387/ijdb.180329jf
PII: 180329jf
Knihovny.cz E-resources
- MeSH
- Cell Nucleolus physiology MeSH
- Time Factors MeSH
- Embryo, Mammalian MeSH
- Embryonic Development MeSH
- Fertilization MeSH
- Heterochromatin physiology MeSH
- Humans MeSH
- Maternal Inheritance MeSH
- Mice MeSH
- Nucleoplasmins genetics MeSH
- Oocytes physiology ultrastructure MeSH
- Animals MeSH
- Zygote physiology MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Heterochromatin MeSH
- Npm2 protein, mouse MeSH Browser
- Nucleoplasmins MeSH
Mammalian oocytes/zygotes contain atypical nucleoli that are composed exclusively of a dense fibrillar material. It has been commonly accepted that these nucleoli serve as a repository of components that are used later on, as the embryo develops, for the construction of typical tripartite nucleoli. Indeed, when nucleoli were removed from immature oocytes (enucleolation) and these oocytes were then matured, fertilized or parthenogenetically activated, development of the produced embryos ceased after one or two cleavages with no detectable nucleoli in nuclei. This indicated that zygotic nucleoli originate exclusively from oocytes, i.e. are maternally inherited. Recently published results, however, do not support this developmental biology dogma and demonstrate that maternal nucleoli in one-cell stage embryos are necessary only during a very short time period after fertilization when they serve as a major heterochromatin organizing structures. Nevertheless, it still remains to be determined, which other functions/roles the atypical oocyte/zygote nucleoli eventually have.
References provided by Crossref.org
Improving the Quality of Oocytes with the Help of Nucleolotransfer Therapy